By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Elite Pharmaceuticals, Inc. 

165 Ludlow Avenue

Northvale  New Jersey  07647  U.S.A.
Phone: 201-750-2646 Fax: 201-750-2755


SEARCH JOBS


Industry
Biotechnology






Company News
Elite Pharmaceuticals, Inc. (ELI) Awarded Second Canadian Patent For Abuse Deterrent Drug Formulation 12/16/2014 7:46:43 AM
Elite Pharmaceuticals, Inc. (ELI) Reports Successful Pivotal Bioequivalence Study For Abuse-Deterrent Oxycodone Product ELI-201 12/4/2014 10:31:39 AM
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The Second Quarter Of Fiscal Year 2015 11/18/2014 6:11:34 PM
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On Wednesday, November 19, 2014 11/14/2014 8:24:12 AM
Elite Pharmaceuticals, Inc. (ELI) Announces New Management Appointments 10/24/2014 10:33:35 AM
Elite Pharmaceuticals, Inc. (ELI) Releases Positive Top Line Human Abuse Liability Data For ELI-200, An Opioid Abuse Deterrent Product 9/9/2014 7:22:32 AM
Elite Pharmaceuticals, Inc. (ELI) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th 9/4/2014 7:54:36 AM
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The First Quarter Of Fiscal Year 2015 8/15/2014 7:59:54 AM
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On August 18, 2014 8/13/2014 7:31:02 AM
Elite Pharmaceuticals, Inc. (ELI) Initiates Pivotal Bioequivalence Study For ELI-201 7/15/2014 10:24:57 AM
12345678910...
//-->